Page 2,045«..1020..2,0442,0452,0462,047..2,0502,060..»

Botox Injections Could Be Used To Treat Stomach Cancer, Experts Say

Posted: August 22, 2014 at 6:01 am

Botox is usually associated with banishing wrinkles, but in the future it could be used to benefit your health.

Botox injections could provide an effective new treatment for stomach cancer, research has shown.

The rejuvenating anti-wrinkle treatment used by numerous celebrities slows tumour growth by blocking nerve signals that stimulate cancer stem cells.

In laboratory tests, Botox - made from the toxin of botulism bacteria - proved "highly effective" at suppressing gastric cancer in mice.

The promising results have led to the launch of an early clinical trial involving human patients with stomach cancer in Norway.

Locally administered Botox mirrored the effect of "vagotomy" - surgical removal of branches of the gastric vagus nerve, which regulates processes linked to digestion.

US lead researcher Dr Timothy Wang, from Columbia University Medical Centre in New York, said: "Scientists have long observed that human and mouse cancers contain a lot of nerves in and around the tumour cells.

"We wanted to understand more about the role of nerves in the initiation and growth of cancer, by focusing on stomach cancer.

"We found that blocking the nerve signals makes the cancer cells more vulnerable - it removes one of the key factors that regulate their growth."

See original here:

Botox Injections Could Be Used To Treat Stomach Cancer, Experts Say

Posted in New York Stem Cells | Comments Off on Botox Injections Could Be Used To Treat Stomach Cancer, Experts Say

Botox could be used as new treatment for stomach cancer, experts say

Posted: August 22, 2014 at 6:01 am

Anti-wrinkle treatment used by celebrities found to slow tumour growth It blocks the nerve signals that stimulate cancer stem cells Lab tests found Botox was 'highly effective' in suppressing gastric cancer Prompted launch of clinical trial using human patients in Norway

By Lizzie Parry for MailOnline

Published: 13:04 EST, 20 August 2014 | Updated: 13:04 EST, 20 August 2014

320 shares

17

View comments

Botox injections could provide an effective new treatment for stomach cancer, research has shown.

The rejuvenating anti-wrinkle treatment used by numerous celebrities slows tumour growth by blocking nerve signals that stimulate cancer stem cells.

In laboratory tests, Botox - made from the toxin of botulism bacteria - proved 'highly effective' at suppressing gastric cancer in mice.

The promising results have led to the launch of an early clinical trial involving human patients with stomach cancer in Norway.

See the original post:

Botox could be used as new treatment for stomach cancer, experts say

Posted in New York Stem Cells | Comments Off on Botox could be used as new treatment for stomach cancer, experts say

New Mexico Stem Cell Treatment | Stem Cell Treatments

Posted: August 22, 2014 at 6:00 am

New Mexico Stem Cell Treatment Worldstemcells.com is one of the leading stem cell therapy and treatment providers for residents of New Mexico and across the nation. Our cutting edge technology and compassionate staff truly set us apart from the competition. We are a US based company that understands your needs and concerns when looking for a stem cell treatment center. Our treatment center is located in Cancun, Mexico.

Conditions we treat include but not limited to:

Getting Started With Your Stem Cell Therapy and Treatments Here at World Stem Cells LLC we try to make the process of receiving stem cell transplants as easy as possible. We will help you figure out what your needs are and help you reach your goals as fast as possible. Follow the steps below on what to do.

Option 1 1.) Go to any page on our website and fill out the contact form. 2.) Fill in the required information and select the condition you would like to treat with stem cell therapy. 3.) Be sure to include any special information in the comments section. 4.) Click the submit button and we will contact you in a timely manner. 5.) Thats it, youre done!!!

REQUEST INFORMATION NOW!

Option 2

Call 800-234-1693 and speak with a representative regarding your stem cell therapy needs and requirements.

View post:

New Mexico Stem Cell Treatment | Stem Cell Treatments

Posted in New Mexico Stem Cells | Comments Off on New Mexico Stem Cell Treatment | Stem Cell Treatments

Regenexx Stem Cell Procedures – New York and New Jersey …

Posted: August 22, 2014 at 6:00 am

In October 2011, the Rehabilitation Medicine Center became the first east-coast clinic licensed and trained to perform the Regenexx Family of Regenerative Medicine Procedures.

These advanced stem cell and blood platelet procedures provide non-surgical treatment options for those suffering from joint or bone pain, torn or strained tendons and ligaments, or other common injuries and degenerative conditions. Regenexx procedures offer a viable alternative for patients with chronic pain and who may be considering surgery.

Stem Cells are in all of us and they are responsible for healing injured bone, ligaments, tendons and tissues. As we get older or injured, we sometimes cannot get enough of these cells into the area in need. The Regenexx Procedures help solve that problem by precisely delivering a high concentration of stem cells into the injured area and aiding your bodys ability to heal naturally. Patients experience very little down time and they typically avoid the long, painful rehabilitation periods that often follow surgery to restore joint strength and mobility.Procedures are performed in our New Jersey office, but evaluations can take place in our New York City or New Jersey clinics.To determine if youre a candidate for these procedures, please complete our Candidate Form.

Regenexx Procedures were recently featured on The Doctors TV show. The episode featured Dr. Christopher J. Centeno and Dr. Ron Hanson from the Centeno-Schultz Clinic in Colorado, along with patient Barbee James, who sought stem cell treatment following traditional knee surgery. The 6 minute video provides a nice overview of the Regenexx-SD (Same Day) Stem Cell procedure, which is now offered at the Rehabilitation Medicine Center.

On February 28, 2013 Seattle King TV featured Regenexx patient Paul Lyon, who underwent a Regenexx-SD knee procedure. The story looks at his results and includes an interview with Dr. Christopher Centeno, founder of the Regenexx Procedures.

If you are suffering from a joint injury, joint pain, a non-healing fracture or a degenerative condition like osteoarthritis, you may be a good candidate for these ground-breaking stem cell and blood platelet treatments. Please complete the Procedure Candidate Form below and we will immediately email you more information.

Download the Free E-Book on Regenerative Orthopedics Orthopedics 2.0 How Regenerative Medicine will Create the Next Generation of Less Invasive Orthopedics. Authored by the Centeno-Schultz clinics Dr. Chris Centeno, this book explains the comprehensive Orthopedics 2.0 approach to patients.

More:

Regenexx Stem Cell Procedures - New York and New Jersey ...

Posted in New Jersey Stem Cells | Comments Off on Regenexx Stem Cell Procedures – New York and New Jersey …

Stem Cells and Cloning – New Jersey Right to Life | Prolife

Posted: August 22, 2014 at 6:00 am

Stem Cells

A stem cell is essentially a blank cell, capable of becoming another more differentiated cell type in the body, such as a skin cell, a muscle cell, or a nerve cell. Microscopic in size, stem cells are big news in medical and science circles because they can be used to replace or even heal damaged tissues and cells in the body. They can serve as a built-in repair system for the human body, replenishing other cells as long as a person is still alive.

Adult stem cells are a natural solution. They naturally exist in our bodies, and they provide a natural repair mechanism for many tissues of our bodies. They belong in the microenvironment of an adult body, while embryonic stem cells belong in the microenvironment of the early embryo, not in an adult body, where they tend to cause tumors and immune system reactions.

Most importantly, adult stem cells have already been successfully used in human therapies for many years. As of this moment, no therapies in humans have ever been successfully carried out using embryonic stem cells. New therapies using adult type stem cells, on the other hand, are being developed all the time.

Source: 2010 Stemcellresearchfacts.org

Cloning-to-produce-children - Production of a cloned human embryo, formed for the (proximate) purpose of initiating a pregnancy, with the (ultimate) goal of producing a child who will be genetically virtually identical to a currently existing or previously existing individual.

Cloning-for-biomedical-research - Production of a cloned human embryo, formed for the (proximate) purpose of using it in research or for extracting its stem cells, with the (ultimate) goals of gaining scientific knowledge of normal and abnormal development and of developing cures for human diseases.

Human cloning - The asexual reproduction of a new human organism that is, at all stages of development, genetically virtually identical to a currently existing, or previously existing, human being. (CR)

Cloned embryo: An embryo arising from the somatic cell nuclear transfer process as contrasted with an embryo arising from the union of an egg and sperm. (CR)

Source: White Paper: Alternative Sources of Pluripotent Stem Cells The President's Council on Bioethics Washington, D.C., May 2005

Visit link:

Stem Cells and Cloning - New Jersey Right to Life | Prolife

Posted in New Jersey Stem Cells | Comments Off on Stem Cells and Cloning – New Jersey Right to Life | Prolife

2013 New Jersey Stem Cell Research Symposium

Posted: August 22, 2014 at 6:00 am

The Seventh Annual New Jersey Stem Cell Research Symposium

Co-sponsored by the Human Genetics Institute of New Jersey and Life Technologies, Inc.

The Seventh Annual New Jersey Stem Cell Research Symposium will be held on September 24, 2013 at the Bridgewater Marriott. Over 240 scientists are expected to attend the day-long event including presentations, posters, and exhibits.

The Sixth Annual New Jersey Stem Cell Research Symposium was a great success with over 250 scientists attending.

Abstract deadline: September 6, 2013. September 13, 2013

Registration deadline: September 13, 2013

Abstracts: The deadline has been extended to accomodate late-breaking results! Participants are invited to submit abstracts for poster presentations. The program committee will select several abstracts for oral presentation. You may begin to submit abstracts at any time, after registering. Begin by following the link to the registration page.

Program: The preliminary agenda is now posted, including leading speakers from key stem cell programs in New Jersey, Connecticut, New York, and Maryland.

See more here:

2013 New Jersey Stem Cell Research Symposium

Posted in New Jersey Stem Cells | Comments Off on 2013 New Jersey Stem Cell Research Symposium

Nevada (Stem Cell) – what-when-how

Posted: August 22, 2014 at 6:00 am

In April 2005, a Nevada university, along with one in Pennsylvania, began discussing the opening of a new medical center in Las Vegas that would incorporate stem cell biology with organ transplants. The University of Pittsburgh Medical Center (UPMC) and the University of Nevada School of Medicine (UNSM) proposed to establish the joint academic medical center in downtown Las Vegas at Union Park. Faculty would come from both universities; however, although the UNSM would profit both financially and intellectually from the new medical center, most of the financial backing would come from UPMC.

On July 18, 2006, the U.S. Senate convened to vote on a proposed bill (H.R.810) that would amend the Public Health Service Act and provide federal funding for research on human embryonic stem cells. This bill was passed by the Senate but was later vetoed by President George W. Bush. In the vote, the two Nevada senators voted against each other: Republican John Ensign was opposed to the bill, and Democrat Harry Reid supported it. Senator Reid helped to introduce another Stem Cell Research Enhancement Act for 2007. It was passed by the U.S. Senate on April 11, 2007, and the House passed it two months later, but President George W. Bush vetoed it later that month.

A doctor in Nevada named Alfred Sapse claims he can cure a wide range of diseases by implanting stem cells from dried placentas under the skin of his patients. He claims to have had astonishingly positive results with test studies in Odessa, Ukraine; however, although Sapse says the results were published, the papers have not been found. Nevertheless, Sapse has established StemCell Pharma Inc., where he acts as president and founder, to conduct his procedures. Sapse has not explained how his technique circumvents the requirement for donated cells to match the HLA, or human leukocyte antigen, haplotype of the recipient; the chance of HLA haplotypes matching between two unrelated individuals is rare.

At the University of Nevada at Reno, scientists are developing the ability to grow human organs in sheep from human stem cells injected into sheep embryos still inside the pregnant ewe. These organs would be used for transplants back into the initial stem cell donor, who would be given bone marrow stem cells. The procedure is still in development as the researchers determine how to ensure that the new organs will be 100 percent human. In addition, the researchers must prove that the carrying animal, here the sheep, does not harbor any diseases that could be transplanted along with the organ. This research is led by Dr. Esmail Zanjani. Also working on stem cell biology at the University of Nevada at Reno are Dr. Graca Almeida-Porada, who is focusing on human stem cell biology, tissue engineering, and stem cell expansion and modulation, and Dr. Christopher Porada, who is working with in utero gene therapy and stem cell transplantation.

Read the original here:

Nevada (Stem Cell) - what-when-how

Posted in Nevada Stem Cells | Comments Off on Nevada (Stem Cell) – what-when-how

Blood and Marrow Transplant – The Nebraska Medical Center …

Posted: August 22, 2014 at 5:59 am

Blood and marrow transplantation is a special treatment procedure which may be appropriate for some cases of multiple myeloma, leukemia and lymphoma.

The Nebraska Medical Center stem cell transplantation program has been ranked as one of the busiest adult and pediatric stem cell transplantation programs in the world. The program, which was established in 1983, has been recognized internationally for pioneering autologous transplantation using peripheral stem cells as an alternative rescue product; conducting ground-breaking transplant studies; and performing transplants in alternate settings other than traditional inpatient hospital units.

The Nebraska Medical Center is the only hospital in the country with two physicians on the National Comprehensive Cancer Network's (NCCN) board of directors and the only National Cancer Center (NCI) designated cancer center in this region of the country. Patients receiving care at The Nebraska Medical Center receive both the clinical expertise of our academic and private practice physicians and have access to new procedures and technology through the work of researchers performing blood and marrow clinical trials at the University of Nebraska Medical Center.

While the transplant procedures take place in the hospital, a patient can move to The Lied Transplant Center for recovery and to participate in cooperative care once they are ambulatory, or able to move around. Cooperative care is a revolutionary approach that allows patients and their care partners to play an active role in the treatment and recovery process following transplantation, cancer care and treatment of other illnesses.

Care partners, usually a family member or friend, assist in all aspects of the recovery process including administering medications, monitoring health changes, attending informational classes and more. The cooperative care environment allows patients and care partners to learn the skills they will need when they return home. Care partners and patients stay in a comfortable home-like suite that includes a private bedroom, bathroom, living room, kitchenette and two televisions. Support groups are also available for those in need of support during and after cancer treatment.

Make an appointment with blood and marrow transplant specialists by calling 800-922-0000. For clinic location and hours use the Find a Physician link.

Bone marrow is the spongy tissue inside the bones, which produces many cells of the blood. In diseases involving the bone marrow, such as leukemia and aplastic anemia, normal bone marrow production has been altered. The bone marrow produces abnormal numbers or abnormal types of blood cells. In other diseases such as lymphoma, testicular cancer and breast cancer, the marrow may or may not be directly affected, but the cancer does involve other cells in the body.

The process of Hematopoietic Cell Transplantation (HCT) is a type of transfusion, not a surgical procedure. In transplantation, the transfusion consists of collecting special cells from the marrow or the blood, called stem cells. These stem cells are an early form of blood cell that produces red blood cells, white blood cells, platelets and additional stem cells. Normally in cancer treatment, the effect of therapy on the bone marrow limits the amount of treatment that can be given. When we give stem cells from the marrow or peripheral blood as a rescue transfusion, it is possible to give higher doses of therapy. This, of course, increases the chances of a good response to the therapy.

The stem cells used for the rescue or recovery are collected from the patient or a donor and then given to the patient after the cancer therapy has been administered. There are different types of transplants; each is named according to the donor of the stem cells. Blood and marrow stem cell transplants are grouped into several categories based on how the stem cells are collected. These include:

See more here:

Blood and Marrow Transplant - The Nebraska Medical Center ...

Posted in Nebraska Stem Cells | Comments Off on Blood and Marrow Transplant – The Nebraska Medical Center …

Nebraska (Stem Cell) – what-when-how

Posted: August 22, 2014 at 5:59 am

Nebraskas history of biomedical research in the academic and medical fields has brought the state national recognition for work such as that of researchers at the University of Nebraska Medical Center, who in 1997 injected liver cells into diseased tissue, resulting in improved function and in the patient no longer needing a liver transplant. However, developments in the legislative area resulting from ethical and social debate may hinder both future innovation and the attracting of top researchers in stem cell research if a research ban and penalty for such research is approved.

As no federal legislation in the United States regulates stem cell research (except by an executive order to not allow federal funding to be used for embryonic stem cell research except on human embryonic stem cell lines created before August 9, 2001), each state is responsible for determining policy and funding for stem cell research. Nebraska law also limits the use of state funds from the tobacco settlement to the state healthcare cash fund from being used for human embryonic stem cell research.

A bill was introduced in 2007 and carried over into 2008 that would ban both human reproductive and therapeutic cloning using somatic cell nuclear transfer. In addition to the ban, the bill seeks to classify this type of research activity as a felony with harsh penalties. Funding for research is available through the National Institutes of Health, state funding, and private foundations and research grants.

Research in the department of virology at the University of Nebraska includes the interaction between the neurological and immune systems and the laboratorys discovery that T cells mount a spontaneous response to protect injured neurons. Their research also includes central nervous system regeneration of damaged retina in a mouse model using rodent embryonic progenitor cells. The long-term goals include returning vision in cells that do not naturally regenerate.

The stem cell and bone marrow transplantation team at the University of Nebraska Medical Center is involved in over 400 research protocols and clinical trials for cancer, heart diseases, diabetes, musculoskeletal disease, and other illnesses. In addition to treatment, the centers research is conducted to improve post-transplant quality of life by reducing transplant-related complications. One such study follows peripheral stem cell transplant patients for sleep disturbances, fatigue, and pain and compares the biological indicators of sleep quality and cycles, as well as determining the effect on caregivers sleep quality and cycles.

After the success in 1997 of injecting liver cells, researchers have turned to studying the possibility of using human embryonic stem cells to create liver cells. The scientists at the University of Nebraska Medical Center are working with National Institutes of Health-approved stem cell lines in mouse models. As with all research, preliminary testing is necessary before federal grant money can be requested, as federal money is limited to research that has been shown to be viable, and even then, funding is very competitive.

The Nebraska Center for Cellular Signaling, established in 2003 through National Institute of Health funding, created a center of biomedical research in Nebraska. The center is the result of collaboration between the University of Nebraska-Lincoln, Creighton Medical School, and the University of Nebraska Medical Center. The centers mission is to improve oral and dental health. To meet this goal, researchers focus on cellular biology (adhesion and motility and cancer biology), with projects on oral and colon cancer, DNA damage, ubiquitin ligases, and signaling.

Nebraskans for Research was formed in 2000 as an advocacy and public education group to support medical research within the state, including stem cell research. The organizations goals are to gain increased funding for biomedical research for economic growth and improved medical treatments for human disease and illnesses, as well as attracting top researchers to the state. To meet this goal, the organization promotes the successes of Nebraska researchers to the public through online content, media coverage, and conferences or lectures showcasing a variety of topics from ethics, to basic research, to accomplishments. With a goal of training future scientists, the group also develops programs for science teachers to use in their classes.

Visit link:

Nebraska (Stem Cell) - what-when-how

Posted in Nebraska Stem Cells | Comments Off on Nebraska (Stem Cell) – what-when-how

Stem Cell Transplantation at Billings Clinic Cancer Center

Posted: August 22, 2014 at 5:59 am

The Billings Clinic Cancer Center is the only facility in the region with stem cell transplantation. Stem cell transplant is the standard of care for certain types of cancers. This means it has been proven to provide the patient with the best outcome for treating their cancer.

Stem cell transplant allows your physician to integrate the use of high dose chemotherapy with the strategies that preserve bone marrow function. Transplant expertise includes the use of mobilized peripheral blood stem cells and bone marrow growth factors to promote recovery from high dose chemotherapy.

Historically, cancer patients receiving high-dose chemotherapy have been required to enter the hospital for lengthy periods. Today, continuing advances in cancer research and treatment make it possible for patients to receive much of their treatment on a strictly-monitored outpatient basis.

Working closely with your physician, the staff of this program will provide the prescribed therapy in the outpatient Infusion Center. You will only be hospitalized when absolutely necessary.

There are basically two types of Stem Cell Transplantation, Autologous and Allogenic. Stem cells are circulating cells, primarily in the blood stream that are the precursor to all other blood cells.

Stem cell transplantation is a procedure in which the stem cells are exchanged. There is a donor and a recipient (patient) in the procedure. When the donor is the patient themselves the transplant is known as an Autologous Stem Cell Transplant and when the donor is not the patient the transplant is called an Allogenic Stem Cell Transplant. The Billings Clinic performs Autologous Stem Cell Transplantation.

The stem cell transplant team is an integrated team of physicians, navigators, dietitians, financial counselors, genetic counselors and social workers that work collaboratively for the patient within the stem cell program. Several registered nurses are specially trained for Autologous Stem Cell Harvesting, or collection of stem cells, for the program.

The cancers that are treated at Billings Clinic with Autologous Stem Cell transplantation include:

The Therapeutic Apheresis Program was added to the Cancer Centers Stem Cell Transplant Program in January of 2010. Therapeutic apheresis is the process of separating specific blood components from a patient to achieve levels that will allow improvement for a number of disorders such as:

Additional stem cell procedures that are performed at Billings Clinic are:

Read more:

Stem Cell Transplantation at Billings Clinic Cancer Center

Posted in Montana Stem Cells | Comments Off on Stem Cell Transplantation at Billings Clinic Cancer Center

Page 2,045«..1020..2,0442,0452,0462,047..2,0502,060..»